Skip to nav Skip to content

Female patient discussing her treatment with her doctor

At Moffitt Cancer Center, Hodgkin lymphoma clinical trials are continually providing our patients with access to newer and more effective treatment options. Through these important research studies, our patients are often able to benefit from novel therapies that aren’t yet available in other settings. These options may include new approaches to bone marrow transplantation, new chemotherapy medications and biologic therapies that use the body’s immune system to fight cancer.

Clinical Trials at Moffitt Cancer Center

Each clinical trial is different, but many of Moffitt’s studies are designed for patients who haven’t achieved remission through standard treatments. Through these unique opportunities, some patients with recurrent lymphoma or failed treatment may find additional options for improving their prognoses and quality of life.

Patients who participate in Moffitt’s clinical trials can also benefit from:

  • Individualized recommendations – Moffitt’s team is here to match each patient with the research opportunities that are most appropriate for his or her unique needs.
  • National Cancer Institute-backed studies – The National Cancer Institute has named Moffitt a Comprehensive Cancer Center, and we are the only such center based in Florida. Many of our research studies are made possible through National Cancer Institute grants, and our Comprehensive Cancer Center designation speaks to our long-standing commitment to innovation, excellence and research.
  • Our translational approach – Constantly working behind the scenes to determine how Hodgkin lymphoma develops, spreads and responds to different treatments, we use everything we learn in the laboratory to directly benefit our patients. Individuals who participate in our clinical trials aren’t just expanding their own options – they’re improving the future of treatment for everyone who faces a Hodgkin lymphoma diagnosis.

A referral is not required to participate in any of our Hodgkin lymphoma clinical trials. For more information, call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online.